174 related articles for article (PubMed ID: 37644575)
1. Clinical indicators that influence a clinician's decision to start L-thyroxine treatment in prematurity with transient hypothyroxinemia.
Yilmaz A; Ozer Y; Kaya N; Cakir AD; Culpan HC; Perk Y; Vural M; Evliyaoglu O
Ital J Pediatr; 2023 Aug; 49(1):105. PubMed ID: 37644575
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors of transient hypothyroxinemia of prematurity: a prospective cohort study.
Maneenil G; Juthong M; Thatrimontrichai A; Janjindamai W; Dissaneevate S; Jaruratanasirikul S
Turk J Pediatr; 2023; 65(4):562-571. PubMed ID: 37661671
[TBL] [Abstract][Full Text] [Related]
3. The factors associated with transient hypothyroxinemia of prematurity.
Yilmaz A; Ozer Y; Kaya N; Turan H; Acar HC; Ercan O; Perk Y; Evliyaoglu O; Vural M
BMC Pediatr; 2021 Aug; 21(1):344. PubMed ID: 34388993
[TBL] [Abstract][Full Text] [Related]
4. Transient hypothyroxinemia of prematurity is associated with abnormal cranial ultrasound and illness severity.
Huang CB; Chen FS; Chung MY
Am J Perinatol; 2002 Apr; 19(3):139-47. PubMed ID: 12012289
[TBL] [Abstract][Full Text] [Related]
5. Effect of levothyroxine supplementation in extremely low birth weight infants with transient hypothyroxinemia of prematurity.
Yoon SA; Chang YS; Yang M; Ahn SY; Sung SI; Cho HS; Park WS
Sci Rep; 2022 Jun; 12(1):9717. PubMed ID: 35690687
[TBL] [Abstract][Full Text] [Related]
6. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
[TBL] [Abstract][Full Text] [Related]
7. Transient hypothyroxinemia of prematurity and its risk factors in an extramural neonatal intensive care unit.
Rai R; Singh DK; Bhakhri BK
Arch Endocrinol Metab; 2021 Nov; 65(6):723-729. PubMed ID: 33909379
[TBL] [Abstract][Full Text] [Related]
8. Response of preterm infants with transient hypothyroxinaemia of prematurity to the thyrotropin-releasing hormone stimulation test is characterized by a delayed decrease in thyroid-stimulating hormone after the peak.
Yamamoto A; Iwanaga K; Matsukura T; Niwa F; Morimoto T; Takita J; Kawai M
Clin Endocrinol (Oxf); 2020 Nov; 93(5):605-612. PubMed ID: 32496604
[TBL] [Abstract][Full Text] [Related]
9. Effect of L-thyroxine supplementation on very low birth weight infants with transient hypothyroxinemia of prematurity at 3 years of age.
Uchiyama A; Kushima R; Watanabe T; Kusuda S
J Perinatol; 2017 May; 37(5):602-605. PubMed ID: 28125093
[TBL] [Abstract][Full Text] [Related]
10. Serum thyroid hormone levels in preterm infants born before 33 weeks of gestation and association of transient hypothyroxinemia with postnatal characteristics.
Dilli D; Oğuz SS; Andiran N; Dilmen U; Büyükkağnici U
J Pediatr Endocrinol Metab; 2010 Sep; 23(9):899-912. PubMed ID: 21175089
[TBL] [Abstract][Full Text] [Related]
11. Does transient hypothyroxinemia influence metabolic bone disease of prematurity?
Demirel U; Özek E; Bereket A; Demirel B; Topuzoğlu A; Akman İ
J Matern Fetal Neonatal Med; 2013 Dec; 26(18):1844-9. PubMed ID: 23672243
[TBL] [Abstract][Full Text] [Related]
12. General Movement assessment and neurodevelopmental trajectory in extremely preterm infants with hypothyroxinaemia of prematurity (THOP).
Goel D; Luig M; Maheshwari R; D'Cruz D; Goyen TA
Early Hum Dev; 2020 May; 144():104886. PubMed ID: 31668678
[TBL] [Abstract][Full Text] [Related]
13. Evolution of circulating thyroid hormone levels in preterm infants during the first week of life: perinatal influences and impact on neurodevelopment.
Eerdekens A; Naulaers G; Ortibus E; Verhaeghe J; Langouche L; Vanhole C
J Pediatr Endocrinol Metab; 2019 Jun; 32(6):597-606. PubMed ID: 31112508
[TBL] [Abstract][Full Text] [Related]
14. Transient hypothyroxinemia of prematurity and problem behavior in young adulthood.
Hollanders JJ; van der Pal SM; Verkerk PH; Rotteveel J; Finken MJ;
Psychoneuroendocrinology; 2016 Oct; 72():40-6. PubMed ID: 27343725
[TBL] [Abstract][Full Text] [Related]
15. No Association Between Transient Hypothyroxinemia of Prematurity and Neurodevelopmental Outcome in Young Adulthood.
Hollanders JJ; Israëls J; van der Pal SM; Verkerk PH; Rotteveel J; Finken MJ;
J Clin Endocrinol Metab; 2015 Dec; 100(12):4648-53. PubMed ID: 26480285
[TBL] [Abstract][Full Text] [Related]
16. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease.
Matsuura N; Harada S; Ohyama Y; Shibayama K; Fukushi M; Ishikawa N; Yuri K; Nakanishi M; Yokota Y; Kazahari K; Oguchi H
Pediatr Res; 1997 Aug; 42(2):214-8. PubMed ID: 9262225
[TBL] [Abstract][Full Text] [Related]
17. Current knowledge of transient hypothyroxinemia of prematurity: to treat or not to treat?
Iijima S
J Matern Fetal Neonatal Med; 2019 Aug; 32(15):2591-2597. PubMed ID: 29447027
[TBL] [Abstract][Full Text] [Related]
18. Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial.
Uchiyama A; Kushima R; Watanabe T; Kusuda S
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):177-82. PubMed ID: 25153575
[TBL] [Abstract][Full Text] [Related]
19. A novel useful marker in the early discrimination of transient hyperthyrotropinemia/hypothyroxinemia and congenital hypothyroidism in preterm infants: thyroid-stimulating hormone/free thyroxine ratio.
Cakir U; Tayman C
J Pediatr Endocrinol Metab; 2024 Jun; 37(6):536-542. PubMed ID: 38662611
[TBL] [Abstract][Full Text] [Related]
20. Response to thyrotropin-releasing hormone stimulation tests in preterm infants with transient hypothyroxinemia of prematurity.
Yamamoto A; Kawai M; Iwanaga K; Matsukura T; Niwa F; Hasegawa T; Heike T
J Perinatol; 2015 Sep; 35(9):725-8. PubMed ID: 26110495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
